Singapore: The All China Biotech Conference and Exhibition will be held on September 21-23 in Nanjing International Expo...
Mindray Medical created a strong name in a wide array of medical devices and consumables. It is further complementing ...
Singapore: DKSH Business Unit Healthcare, service provider for healthcare companies seeking to grow their business in As...
Singapore: Australia firm focused on sleep disorder, ResMed, has completed the previously announced acquisition of China...
Singapore: Buchang Pharma is likely to significantly increase its stake in the Tianyin-Buchang Alliance joint venture, t...
Singapore: US based Cambridge Technology (CTI) has launched its first research and development center in China to provid...
Singapore: A report published on February 11 by the Hyundai Economic Research Institute titled, 'Comparison of Korea-Chi...
Singapore: China's WuXi PharmaTech and TruTag Technologies, developer of an innovative edible security platform for phar...
Singapore: 3SBio, China-based biotechnology company focused on researching, developing, manufacturing and marketing biop...
Sino Biopharmaceutical, an integrated name in R&D, manufacturing and marketing of health enhancing modernized Chin...
Singapore: The Chinese State Food and Drug Administration (SFDA) will implement a regulation on the management of a drug...
Singapore: China Resources Sanjiu Medical & Pharmaceutical plans to fully acquire Zhejiang Zhongyi Pharmaceutical in...
Singapore: WuXi PharmaTech's small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmace...
‎Singapore: Mundipharma, an Asian pharmaceutical company, has launched Flutiform (fluticasone propionate/formotero...
Singapore: With a capital of $30 million, Tokyo based Chugai Pharmaceutical has announced to establish a wholly owned dr...
Singapore: China-based WuXiPharmaTech, pharmaceutical, biotechnology and medical device research and development outsour...
Singapore: China Jo-Jo Drugstores, China's wholesale distributor of pharmaceutical and health care products through onli...
Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-...
